bisantrene has been researched along with Bone Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Coltman, CA; Kuhn, JG; Myers, JW; Pocelinko, R; Rivkin, S; Van Echo, D; Von Hoff, DD | 1 |
1 other study(ies) available for bisantrene and Bone Neoplasms
| Article | Year |
|---|---|
Phase II evaluation of bisantrene in patients with renal cell carcinoma.
Topics: Adenocarcinoma; Adult; Aged; Anthracenes; Antibiotics, Antineoplastic; Bone Neoplasms; Drug Evaluation; Female; Humans; Leukocyte Count; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged | 1982 |